ZW13480A1 - Hypocholesteremic fermentation products and process of preparation - Google Patents

Hypocholesteremic fermentation products and process of preparation

Info

Publication number
ZW13480A1
ZW13480A1 ZW134/80A ZW13480A ZW13480A1 ZW 13480 A1 ZW13480 A1 ZW 13480A1 ZW 134/80 A ZW134/80 A ZW 134/80A ZW 13480 A ZW13480 A ZW 13480A ZW 13480 A1 ZW13480 A1 ZW 13480A1
Authority
ZW
Zimbabwe
Prior art keywords
hypocholesteremic
preparation
fermentation products
fermentation
products
Prior art date
Application number
ZW134/80A
Other languages
English (en)
Inventor
Richard Leo Monaghan
Alfred William Alberts
Carl Herman Hoffman
Schonberg George Albers
Henry Joshua
Maria Begona Lopez
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27367450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZW13480(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/048,946 external-priority patent/US4231938A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZW13480A1 publication Critical patent/ZW13480A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/66—Aspergillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZW134/80A 1979-06-15 1980-06-06 Hypocholesteremic fermentation products and process of preparation ZW13480A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/048,946 US4231938A (en) 1979-06-15 1979-06-15 Hypocholesteremic fermentation products and process of preparation
US7780779A 1979-09-21 1979-09-21
US11445980A 1980-01-23 1980-01-23

Publications (1)

Publication Number Publication Date
ZW13480A1 true ZW13480A1 (en) 1982-02-03

Family

ID=27367450

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW134/80A ZW13480A1 (en) 1979-06-15 1980-06-06 Hypocholesteremic fermentation products and process of preparation

Country Status (20)

Country Link
EP (1) EP0022478B1 (enExample)
AR (1) AR224008A1 (enExample)
AT (1) ATE2620T1 (enExample)
AU (1) AU535944B2 (enExample)
CA (1) CA1161380A (enExample)
DD (1) DD157344A5 (enExample)
DE (1) DE3062122D1 (enExample)
DK (1) DK149003C (enExample)
EG (1) EG16957A (enExample)
ES (1) ES492384A0 (enExample)
FI (1) FI67231C (enExample)
GR (1) GR69216B (enExample)
IE (1) IE49685B1 (enExample)
IL (1) IL60219A (enExample)
NO (1) NO155699C (enExample)
NZ (1) NZ193922A (enExample)
PL (1) PL125843B1 (enExample)
PT (1) PT71371B (enExample)
RO (1) RO79487A (enExample)
ZW (1) ZW13480A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925599B2 (ja) * 1979-02-20 1984-06-19 三共株式会社 新生理活性物質モナコリンｋおよびその製造法
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
DE8533814U1 (de) * 1985-11-30 1986-01-16 Beiersdorf Ag, 2000 Hamburg Vorrichtung zum Spülen des Darmes
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
DE3739882A1 (de) * 1987-11-25 1989-06-08 Bayer Ag Substituierte hydroxylamine
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
AU618158B2 (en) * 1989-01-07 1991-12-12 Bayer Aktiengesellschaft New substituted pyrido(2,3-d)pyrimidines
DE3911064A1 (de) * 1989-04-06 1990-10-11 Bayer Ag Substituierte 1,8-naphthyridine
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
CA2062023A1 (en) * 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
NZ245713A (en) * 1992-02-10 1994-12-22 Novopharm Ltd Production of the antibiotic lovastatin from genetically engineered aspergillus strains
WO1993017991A1 (en) * 1992-03-04 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
DE4244029A1 (de) * 1992-12-24 1994-06-30 Bayer Ag Neue substituierte Pyridine
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
NZ286920A (en) * 1995-07-03 1997-06-24 Sankyo Co Use of combination of hmg-coa reductase inhibitors and of insulin sensitizers for the prevention/treatment of arteriosclerosis or xanthoma
EP0795554A3 (en) * 1996-03-05 1998-01-28 Takeda Chemical Industries, Ltd. (Oxo-)xanthene derivatives, their preparation and their use as immunomodulators
PT970236E (pt) * 1997-02-20 2006-08-31 Dsm Ip Assets Bv Producao fermentativa de compostos valiosos a escala industrial utilizando meios quimicamente definidos
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
SI9800057A (sl) 1998-02-26 1999-08-31 Krka, Tovarna Zdravil, D.D. Postopek za pripravo simvastatina in njegovih derivatov
PT2359826E (pt) 2006-07-05 2014-01-20 Takeda Gmbh Combinação de um inibidor da hmg-coa redutase rosuvastatina e um inibidor da fosfodiesterase 4, tais como roflumilaste, óxido de n-roflumilaste, para o tratamento de doenças pulmonares inflamatórias
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049495A (en) * 1974-06-07 1977-09-20 Sankyo Company Limited Physiologically active substances and fermentative process for producing the same
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent

Also Published As

Publication number Publication date
EP0022478A1 (en) 1981-01-21
ATE2620T1 (de) 1983-03-15
IE49685B1 (en) 1985-11-27
PT71371B (en) 1981-10-21
DK254180A (da) 1980-12-16
AU5901780A (en) 1980-12-18
EP0022478B1 (en) 1983-02-23
DD157344A5 (de) 1982-11-03
NZ193922A (en) 1982-05-25
NO155699B (no) 1987-02-02
FI67231B (fi) 1984-10-31
NO801775L (no) 1980-12-16
AU535944B2 (en) 1984-04-12
PL125843B1 (en) 1983-06-30
IL60219A (en) 1985-05-31
IL60219A0 (en) 1980-09-16
CA1161380A (en) 1984-01-31
PT71371A (en) 1980-07-01
DK149003C (da) 1986-08-18
GR69216B (enExample) 1982-05-07
DK149003B (da) 1985-12-16
ES8105389A1 (es) 1981-06-01
AR224008A1 (es) 1981-10-15
IE801232L (en) 1980-12-15
FI67231C (fi) 1985-02-11
DE3062122D1 (en) 1983-03-31
EG16957A (en) 1990-06-30
NO155699C (no) 1987-05-13
PL224920A1 (enExample) 1981-03-27
FI801857A7 (fi) 1980-12-16
ES492384A0 (es) 1981-06-01
RO79487A (ro) 1982-07-06

Similar Documents

Publication Publication Date Title
ZA803545B (en) Hypocholesteremie fermentation products and process of preparation
AU530494B2 (en) Preparation of speroidally shaped products
EG16957A (en) Process for preparing of hypocholesteremic fermentation products
GB2096878B (en) Process of preparing food products
DE2966598D1 (en) Process for the preparation of thienamycin and intermediates
GB2008923B (en) Process for manufacture of cheese and cheese-linke products and materials therofor
GB2056251B (en) Manufacture of food products
AU539654B2 (en) Analysis of meat products
PT71936B (en) Process for the preparation of fermented type sausages
GB2035776B (en) Process and products for the manufacture of cheese products
JPS54163888A (en) Production and use of fixed enzyme product
DE3066747D1 (en) Rhodomycin-group of antibiotics and process for preparing same
DE2965280D1 (en) Preparations of clotrimazole and process for preparing same
DE2860112D1 (en) Carboxylate groups containing addition products of polyisocyanates and process for their preparation
AU531148B2 (en) Fermentation process and apparatus
EP0018681A3 (en) Process for the preparation of alkoxyalkanoic acids, and alkoxyalkanoic acids so prepared
GB2058063B (en) Process for the preparation of 2-mercaptoalkyl-sulphides and 2-mercaptoalkylethers
PT69375A (en) Disposable product and process of manufacture thereof
DE3067697D1 (en) 1-azolyl-1-halogen-alkan-2-ones and process for the preparation of 1-azolyl-1-phenoxy-alkan-2-ones
PH16913A (en) Hypocholesteremic fermentation products and process of preparation
EG14897A (en) Improvements in the process for the preparation of cephalosporins and intermediates employed therein
IL59873A0 (en) Process for the preparation of styrylcyclopropanecarboxylic acid esters and intermediate products for this process
ZA795895B (en) Ravidomycin and process of preparation
HRP940098B1 (en) Process for the preparation of hypocholesteremic fermentation products
AU525528B2 (en) Process forthe treatment of whey and whey permeate and products resulting therefrom